As of April 30, 2026, no new social media or news activity has been recorded for Dementia_with_Lewy_bodies. Dementia with Lewy bodies (DLB) is a type of dementia characterized by changes in sleep, behavior, cognition, movement, and regulation of automatic bodily functions. Unlike some other dementias, memory loss may not be an early symptom. The disease worsens over time and is usually StarFeed automatically checks for new updates every 6 hours. Use the day-by-day view above to see activity from other dates.
← Full profile
Dementia_with_Lewy_bodies on April 30, 2026: news, posts & full activi
FAQ
Q.What did Dementia_with_Lewy_bodies do on April 30, 2026?
As of April 30, 2026, no new social media or news activity has been recorded for Dementia_with_Lewy_bodies yet. StarFeed automatically checks news outlets, Twitter, Instagram, YouTube and other platforms every 6 hours, so new updates may appear soon. Use the day-by-day view above to browse activity from other dates.
Q.Who is Dementia_with_Lewy_bodies?
Dementia with Lewy bodies (DLB) is a type of dementia characterized by changes in sleep, behavior, cognition, movement, and regulation of automatic bodily functions. Unlike some other dementias, memory loss may not be an early symptom. The disease worsens over time and is usually
Q.Where can I see Dementia_with_Lewy_bodies's recent activity?
The Dementia_with_Lewy_bodies profile page on StarFeed organizes all activity from the past 14 days by day. The weekly summary pages also let you see a full week's events at a glance.
Activities
bing-news
Zervimesine slows symptom progression at 6 months in dementia with Lewy bodies Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...
bing-news
Zervimesine slows symptom progression at 6 months in dementia with Lewy bodies Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...
bing-news
Zervimesine slows symptom progression at 6 months in dementia with Lewy bodies Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...
bing-news
Zervimesine slows symptom progression at 6 months in dementia with Lewy bodies Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...
bing-news
Zervimesine slows symptom progression at 6 months in dementia with Lewy bodies Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...
bing-news
Zervimesine slows symptom progression at 6 months in dementia with Lewy bodies Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...
bing-news
Zervimesine slows symptom progression at 6 months in dementia with Lewy bodies Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...
bing-news
Zervimesine slows symptom progression at 6 months in dementia with Lewy bodies Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...
bing-news
Zervimesine slows symptom progression at 6 months in dementia with Lewy bodies Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...
bing-news
Zervimesine slows symptom progression at 6 months in dementia with Lewy bodies Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...